|
|
|
Volumn 25, Issue 3, 1998, Pages 356-360
|
|
Intraperitoneal therapy of ovarian cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
PACLITAXEL;
CANCER COMBINATION CHEMOTHERAPY;
CANCER LOCALIZATION;
CANCER SIZE;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
FEMALE;
HUMAN;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
OVARY CARCINOMA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
CLINICAL TRIALS;
FEMALE;
HUMANS;
INJECTIONS, INTRAPERITONEAL;
OVARIAN NEOPLASMS;
PACLITAXEL;
SALVAGE THERAPY;
|
|
EID: 0031745089
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (82)
|
|
References (17)
|
